Further evidence for clozapine as a dopamine D1 receptor agonist

European Journal of Pharmacology

Volumn 307, Issue 1, 1996, Pages 27-31

  Salmi, Peter ^a,b   Ahlenius, Sven ^a  

^a Behav and Biochemical Pharmacology   (Sweden)

^b STOCKHOLM UNIVERSITY   (Sweden)

Author keywords

Clozapine; Dopamine; Dopamine receptor; Rat; Thermoregulation

Indexed keywords

5 (2,3 DIHYDROBENZOFURAN 7 YL) 2,3,4,5 TETRAHYDRO 3 METHYL 8 NITRO 1H 3 BENZAZEPIN 7 OL; CLOZAPINE; CLOZAPINE N OXIDE; DOPAMINE 1 RECEPTOR BLOCKING AGENT; DOPAMINE 1 RECEPTOR STIMULATING AGENT; DRUG METABOLITE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; CORE TEMPERATURE; DRUG ANTAGONISM; HYPOTHERMIA; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; SUBCUTANEOUS DRUG ADMINISTRATION; THERMOREGULATION;

EID: 0030594576     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/0014-2999(96)00181-1     Document Type: Article

References (30)

1. 1 receptor, J. Neurochem. 47, 1822.
2. 1 receptor antagonists, Eur. J. Pharmacol. 219, 45.
3. Baldessarini, R.J., F. Centorrino, J.G. Flood, S.A. Volpicelli, D. Huston-Lyons and B.M. Cohen, 1993, Tissue concentrations of clozapine and its metabolites in the rat, Neuropsychopharmacology 9, 117.
4. 2) receptors, Eur. J. Pharmacol. 129, 212.
5. Casey, D.E., 1989, Clozapine: neuroleptic-induced EPS and tardive dyskinesia, Psychopharmacology 99, S47.
6. Chipkin, R.E. and M.B. Latranyi, 1987, Similarity of clozapine and SCH 23390 in reserpinized rats suggests a common mechanism of action, Eur. J. Pharmacol. 136, 371.
7. Coward, D.M., A. Imperato, S. Urwyler and T.G. White, 1989, Biochemical and behavioural properties of clozapine, Psychopharmacology 99, S6.
8. Davidson, M., P.H. Harvey, R.L. Bergman, P. Powchik, R. Kaminsky, M.F. Losonczy and K.L. Davis, 1990, Effects of the D-1 agonist SKF-38393 combined with haloperidol in schizophrenic patients, Arch. Gen. Psychiatry 47, 190.
9. 1 agonist, CY 208-243, in de novo patients with Parkinson disease. Movement Disorders 7, 239.
10. 2 agonists and antagonists on experimental gastric lesions and gastric acid secretion. J. Pharmacol. Exp. Ther. 251, 726.
11. 1 receptor antagonist, SCH 23390, Life Sci. 56, 365.
12. Hyttel, J., 1983, SCH 23390-the first selective dopamine D-1 receptor antagonist. Eur. J. Pharmacol. 91, 153.
13. 1 receptor agonist?, Eur. J. Pharmacol. 282, 137.
14. 1C receptor antagonists, Eur. J. Pharmacol. - Mol. Pharmacol. Sect. 245, 179.
15. Maj, J., H. Sowinska, L. Baran and W. Palider, 1974, The central action of clozapine, Pol. J. Pharmacol. Pharm. 26, 425.
16. 3 receptors, Mol. Pharmacol. 43, 749.
17. Meltzer, H.Y., B. Bastani, L. Ramirez and S. Matsubara, 1989, Clozapine: new research on efficacy and mechanism of action, Eur. Arch. Psychiatry Neurol. Sci. 238, 332.
18. 2 receptor-mediated function: behavioural indices, Eur. J. Pharmacol. 186, 79.
19. Reynolds, G.P. and C. Czudele, 1995, New approaches to the drug treatment of schizophrenia, Adv. Pharmacol. 32, 461.
20. Safferman, A.Z., J.M. Kane, J.S. Aronowitz, M.F. Gordon, S. Pollack and J.A. Lieberman, 1994, The use of clozapine in neurological disorders, J. Clin. Psychiatry (Suppl. B) 55, 98.
21. 2 receptors in the regulation of body temperature in the rat, Eur. J. Pharmacol. 236, 395.
22. Salmi, P., T. Karlsson and S. Ahlenius, 1994, Antagonism by SCH 23390 of clozapine-induced hypothermia in the rat, Eur. J. Pharmacol. 253, 67.
23. Scholz, E. and J. Dichgans, 1985, Treatment of drug-induced exogenous psychosis in parkinsonism with clozapine and fluperlapine, Eur. Arch. Psychiatry Neurol. Sci. 235, 60.
24. Tamminga, C.A. and J. Gerlach, 1987, New neuroleptics and experimental antipsychotics in schizophrenia, in: Psychopharmacology: The Third Generation of Progress, ed. H.Y. Meltzer (Raven Press, New York) p. 1129.
25. 1 agonist, reduces MPTP-induced parkinsonism in monkeys, Eur. J. Pharmacol. 199, 389.
26. 4 receptor with high affinity for the antipsychotic clozapine, Nature 350, 610.
27. 4 receptor variants in the human population, Nature 358, 149.
28. 1 receptor agonist, SKF 81297, stimulates motor behaviour of MPTP-lesioned monkeys, Eur. J. Pharmacol, 235, 143.
29. Weigmann, H. and C. Hiemke, 1992, Determination of clozapine and its major metabolites in human serum using automated solid-phase extraction and subsequent high-performance liquid chromatography with ultraviolet detection, J. Chromatogr. 583, 209.
30. Winer, B.J., 1971, Statistical Principles in Experimental Design (McGraw-Hill, New York).